May 15
|
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
|
May 4
|
AtriCure, Inc. (NASDAQ:ATRC) Just Reported, And Analysts Assigned A US$47.33 Price Target
|
May 3
|
The past three years for AtriCure (NASDAQ:ATRC) investors has not been profitable
|
May 3
|
AtriCure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
May 2
|
AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript
|
May 2
|
AtriCure Inc (ATRC) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
|
May 2
|
Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics
|
May 1
|
AtriCure Inc (ATRC) Surpasses Revenue Estimates in Q1 2024 Despite Wider Losses
|
May 1
|
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates
|
May 1
|
AtriCure Reports First Quarter 2024 Financial Results
|
Apr 30
|
AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference
|
Apr 19
|
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
|
Apr 18
|
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
|
Apr 10
|
AtriCure to Announce First Quarter 2024 Financial Results
|
Mar 26
|
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 22
|
AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug
|
Mar 7
|
Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC)
|
Dec 20
|
AtriCure to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
|
Sep 11
|
Unveiling AtriCure (ATRC)'s Value: Is It Really Priced Right? A Comprehensive Guide
|